TL;DR
This study reveals that tau filaments in the rare neurodegenerative diseases ALS/PDC (found in Guam and Japan) share the same structural fold as those found in Chronic Traumatic Encephalopathy (CTE). This discovery strengthens the hypothesis that ALS/PDC, like CTE, may be triggered by environmental factors.
What Problem Does This Paper Address?
Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex (ALS/PDC) is a devastating neurodegenerative disease that affects specific populations, notably on the island of Guam and the Kii peninsula of Japan. Its cause remains unknown, but it's characterized by the accumulation of abnormal tau protein filaments in the brain and spinal cord. While tau pathology is a hallmark of many neurodegenerative diseases, the specific structural forms of these filaments can vary and are thought to be linked to disease mechanisms and origins. Previous research has identified distinct tau filament structures in diseases like Alzheimer's Disease (AD) and CTE. This paper aims to precisely characterize the structure of tau filaments in ALS/PDC to understand its relationship with other tauopathies and shed light on its potential causes.
Methods
The researchers employed electron cryo-microscopy (cryo-EM) to determine the high-resolution structures of tau filaments extracted from brain and spinal cord tissues of ALS/PDC patients. This technique involves flash-freezing samples and imaging them with an electron microscope to visualize the molecular structures. They used optimized extraction procedures to isolate the tau filaments from limited tissue samples. The structural determination involved helical reconstruction, a computational method used to build 3D models of filamentous structures from the 2D cryo-EM images. They compared these newly determined structures to existing high-resolution structures of tau filaments from other diseases, such as CTE, using root-mean-square deviation (rmsd) calculations to quantify structural similarity.
Datasets
The study utilized post-mortem brain and spinal cord tissues from three cases of ALS/PDC from Guam and eight cases from the Kii peninsula of Japan. These tissues served as the source for extracting tau filaments. The researchers also used existing, publicly available cryo-EM structures of tau filaments from Chronic Traumatic Encephalopathy (CTE) for comparison.
Key Insights and Ideas
- Shared Fold, Shared Origin? The most striking finding is that tau filaments from ALS/PDC are structurally identical to those found in CTE. This suggests a common mechanism of tau aggregation, potentially driven by similar external triggers.
- A New Tau Filament Type: The researchers identified a novel subtype of CTE tau filament, termed "CTE Type III," characterized by antiparallel packing of protofilaments. This adds to the growing complexity of tau filament structures.
- Environmental Clues: Given that CTE is strongly linked to head trauma and subacute sclerosing panencephalitis (SSPE) to measles infection, and both these conditions also exhibit CTE-type tau filaments, the discovery in ALS/PDC further supports the hypothesis that this disease may also be caused by exogenous (environmental) factors.
- Location Matters: Similar to CTE and SSPE, tau inclusions in ALS/PDC are predominantly found in cortical layers II/III, distinguishing it from Alzheimer's disease where they are more prevalent in deeper cortical layers.
Key Results
- Tau filaments from both Guam and Kii ALS/PDC cases adopted the CTE tau fold.
- The structures of Type I and Type II CTE tau filaments from ALS/PDC were found to be identical to those from CTE, with very low rmsd values (0.28 Å for Type I, 1.36 Å for Type II).
- A new CTE Type III tau filament was identified in Guam ALS/PDC, characterized by antiparallel protofilament packing.
- In addition to CTE-type filaments, paired helical tau filaments (PHFs) were found in three Kii cases, and filaments with the corticobasal degeneration (CBD) fold were observed in one Kii case.
- TMEM106B filaments and Aß42 filaments were also detected in some cases, indicating a potential for multi-protein pathology.
Limitations and Future Work
The authors acknowledge that for some filament types, there were insufficient images for high-resolution reconstruction, meaning their identification was based on 2D class averages. They also note that the presence of other protein aggregates like Aß, α-synuclein, and TDP-43 in ALS/PDC suggests it might be a "multiple proteinopathy," and that different extraction methods can reveal different filament types, highlighting the complexity of studying these diseases.
Future work could focus on identifying the specific environmental trigger(s) responsible for inducing the CTE tau fold in ALS/PDC. Further investigation into the functional consequences of the newly identified CTE Type III filament and the interplay between different protein aggregates in ALS/PDC would also be valuable. Understanding the precise mechanisms by which environmental factors lead to this specific tau pathology could pave the way for novel diagnostic and therapeutic strategies.
Summary updated